# Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease

> **NCT07020026** · PHASE2 · RECRUITING · sponsor: **Michael J. Fox Foundation for Parkinson's Research** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** [18F]PI-2620

## Key facts

- **NCT ID:** NCT07020026
- **Lead sponsor:** Michael J. Fox Foundation for Parkinson's Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-12
- **Primary completion:** 2027-04
- **Final completion:** 2027-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07020026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07020026, "Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07020026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*